arrow
K

Kristian Holm

oslo university hospital rikshospitalet
H指数:34
被引数:4,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Non-targeted lipidomic profiling reveals distinct molecular signatures in inflammatory bowel disease: Discovery and validation in two inception cohorts

非靶向脂质组学分析揭示炎症性肠病的特异分子特征:两项起始队列的研究发现与验证

2026-01-010
PRE
Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation

地理无关的黏膜微生物群改变在原发性硬化性胆管炎患者中肝移植后持续存在

2025-12-220
OAAI
Tryptophan–kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency

色氨酸–犬尿氨酸代谢物与常见变异型免疫缺陷中的炎症和免疫学表型相关。

2025-05-140
OAAI
RETRACTION: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency (vol 9, 167, 2019) (Retraction of Vol 9, art no 167, 2019)
2024-02-140
OAAI
Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV

肠道菌群改变和循环咪唑丙酸水平与HIV感染者阻塞性冠状动脉疾病相关

2024-01-098
OAAI
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
2022-03-1749
OA
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
2021-08-0144
OAAI